Veterinary infectious diseases are the diseases that can get transmitted from one animal to another animal or another human being. The importance of livestock is enormous for dairy, meat, poultry and textile industries. But the requirement of all these industries is a healthy livestock.
Veterinary infectious diseases is a threat not just to the animals but also for the human population, and hence the veterinary infectious disease therapeutics market is equally important and a swiftly growing market.
As per the data of United States Department of Agriculture the production of milk in the U.S. alone is more than 212 billion pound in 2016, and the federally inspected meat and poultry production was 94.3 billion in 2015.
All this production demands a healthy livestock, but infectious diseases are a common problem for these industries. For the best productivity of these industries veterinary infectious disease therapeutics market needs to grow.
The major factors that are most likely to drive the growth of veterinary infectious disease therapeutics market are the increasing demand for dairy, meat and poultry products due to the ever increasing population size and better standards of living.
Other factors responsible for the growth of veterinary infectious disease therapeutics market includes the increasing awareness about the propagation of various zoonotic diseases (diseases that can be transmitted from animals to humans). Government measures to ensure food security is also responsible for the growth of veterinary infectious disease therapeutics market.
The increase in the number of government or other non-profit organizations that work for the well-being of animal can also drive the market for veterinary infectious disease therapeutics.
The biggest challenges that the veterinary infectious disease therapeutics market is expected to face is the lack of awareness in the developing countries about animal health issues. Another factor that can limit the growth of veterinary infectious disease therapeutics market is the less number of veterinarians in the regions like the Middle East and Africa.
The market for veterinary infectious disease therapeutics market has seen a significant growth in the past few years owing to the increasing awareness of people about the zoonotic diseases and their propagation. A significant advancement in the veterinary infectious disease therapeutics technology is also increasing the vertices of the market.
There is a huge variety of drugs that can be used as antiinfectives for animals including specific drugs for diseases like malaria and tuberculosis. Veterinary infectious disease therapeutics market is expected to see a high CAGR in the forecast period due to the government measures that try to improve the condition and well-being of animals.
A significant proportion of cattle population is present in the developing countries like India, China, Brazil but the lack of awareness and lesser developed economy in these countries inhibit the growth of veterinary infectious disease therapeutics market.
Developed markets like North American and European markets have seen rapid growth in the last few years, and the growth rate is expected to rise over the forecast period in North America, Europe, and Asia Pacific but the growth rate is expected to be slower in the regions of the Middle East and Africa due to less GDP and disposable income in this region.
The major players involved in the production of veterinary infectious disease therapeutics includes Elanco Animal Health, Novartis Animal Health Inc., Merck & Co. Inc., Pfizer Animal Health and Sanofi.
The research report presents a comprehensive assessment of the market and contains thoughtful insights, facts, historical data, and statistically supported and industry-validated market data. It also includes projections using a suitable set of assumptions and methodologies. The research report provides analysis and information according to market segments such as geographies, application, and industry.
The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.
The market for veterinary infectious disease therapeutics can be segmented by types of drug, type of animal and end user.
On the basis of drug type
On the basis of animal type
On the basis of end user
Our Research Products
The "Full Research Suite" delivers actionable market intel, deep dives on markets or technologies, so clients act faster, cut risk, and unlock growth.
The Leaderboard benchmarks and ranks top vendors, classifying them as Established Leaders, Leading Challengers, or Disruptors & Challengers.
Locates where complements amplify value and substitutes erode it, forecasting net impact by horizon
We deliver granular, decision-grade intel: market sizing, 5-year forecasts, pricing, adoption, usage, revenue, and operational KPIs—plus competitor tracking, regulation, and value chains—across 60 countries broadly.
Spot the shifts before they hit your P&L. We track inflection points, adoption curves, pricing moves, and ecosystem plays to show where demand is heading, why it is changing, and what to do next across high-growth markets and disruptive tech
Real-time reads of user behavior. We track shifting priorities, perceptions of today’s and next-gen services, and provider experience, then pace how fast tech moves from trial to adoption, blending buyer, consumer, and channel inputs with social signals (#WhySwitch, #UX).
Partner with our analyst team to build a custom report designed around your business priorities. From analysing market trends to assessing competitors or crafting bespoke datasets, we tailor insights to your needs.
Supplier Intelligence
Discovery & Profiling
Capacity & Footprint
Performance & Risk
Compliance & Governance
Commercial Readiness
Who Supplies Whom
Scorecards & Shortlists
Playbooks & Docs
Category Intelligence
Definition & Scope
Demand & Use Cases
Cost Drivers
Market Structure
Supply Chain Map
Trade & Policy
Operating Norms
Deliverables
Buyer Intelligence
Account Basics
Spend & Scope
Procurement Model
Vendor Requirements
Terms & Policies
Entry Strategy
Pain Points & Triggers
Outputs
Pricing Analysis
Benchmarks
Trends
Should-Cost
Indexation
Landed Cost
Commercial Terms
Deliverables
Brand Analysis
Positioning & Value Prop
Share & Presence
Customer Evidence
Go-to-Market
Digital & Reputation
Compliance & Trust
KPIs & Gaps
Outputs
Full Research Suite comprises of:
Market outlook & trends analysis
Interviews & case studies
Strategic recommendations
Vendor profiles & capabilities analysis
5-year forecasts
8 regions and 60+ country-level data splits
Market segment data splits
12 months of continuous data updates
DELIVERED AS:
PDF EXCEL ONLINE
Veterinary Infectious Disease Diagnostics Market Size and Share Forecast Outlook 2025 to 2035
Infectious Disease Diagnostics Market Size and Share Forecast Outlook 2025 to 2035
Infectious Disease Molecular Diagnostics Market Size and Share Forecast Outlook 2025 to 2035
The lung disease therapeutics market is segmented by disease type, treatment type and distribution channel from 2025 to 2035
Veterinary Respiratory Disease Treatment Market Size and Share Forecast Outlook 2025 to 2035
Veterinary Auto-Immune Therapeutics Market Growth - Trends & Forecast 2025 to 2035
Equine Veterinary Therapeutics Market Is Segmented by Drugs, Vaccines, Indication, Route of Administration and Distribution Channel from 2025 to 2035
Pleural Diseases Therapeutics Market – Drug Trends & Future Outlook 2025 to 2035
Sandhoff Disease Therapeutics Market Size and Share Forecast Outlook 2025 to 2035
Veterinary Neurodegenerative Disease Diagnostics Market Size and Share Forecast Outlook 2025 to 2035
Autoimmune Disease Therapeutics Market Analysis – Size, Share, & Forecast Outlook 2025 to 2035
Marburg Virus Disease Therapeutics Market - Growth & Vaccine Advances 2025 to 2035
Niemann-Pick Disease Type C Therapeutics Market
Rosai-Dorfman Disease (RDD) Therapeutics Market Size and Share Forecast Outlook 2025 to 2035
Pelvic Inflammatory Disease Therapeutics Market
Veno-Occlusive Hepatic Disease Therapeutics Market Size and Share Forecast Outlook 2025 to 2035
Paediatric Respiratory Disease Therapeutics Market
Gastroesophageal Reflux Disease Therapeutics Market Analysis - Innovations & Forecast 2025 to 2035
Late Stage Chronic Kidney Disease Therapeutics Market Size and Share Forecast Outlook 2025 to 2035
Veterinary Point of Care Diagnostics Market Size and Share Forecast Outlook 2025 to 2035
Thank you!
You will receive an email from our Business Development Manager. Please be sure to check your SPAM/JUNK folder too.
Chat With
MaRIA